J Drugs Dermatol. 2021 Jan 1;20(1):106-108. doi: 10.36849/JDD.5400.
Case Scenerio: A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections.
一位 26 岁的患者因严重结节囊肿性瘢痕性痤疮就诊皮肤科。该患者为跨性别男性，并表示过去 4 年每周接受一次肌肉内注射睾酮进行激素替代治疗。
